How much antibiotic suspension is enough?

被引:5
作者
Dusdieker, LB
Murph, JR
Milavetz, G
机构
[1] Univ Iowa, Coll Med, Dept Pediat, Iowa City, IA 52242 USA
[2] Univ Iowa, Coll Pharm, Div Clin Adm Pharm, Iowa City, IA 52242 USA
关键词
antibiotic dispensing; suspensions; measuring devices;
D O I
10.1542/peds.106.1.e10
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objectives. Pilot data suggest that inadequate antibiotic volumes are often dispensed. Study goals were to determine the frequency of inadequate antibiotic volumes dispensed by local pharmacies, develop prescription-writing guidelines to ensure that adequate antibiotic suspension volumes are dispensed, and document the adequacy of verbal/written counseling pharmacists provide. Methods. Sixty-one local pharmacies filled prescriptions for penicillin potassium (PCN; 250 mg/5 mL [5 mL orally 3 times daily for 10 days]) and Bactrim (trimethoprim-sulfamethoxazole [TMP-SMX] 5 mL orally twice daily for 10 days). The prescriptions noted only to "dispense a 10-day supply." Volumes were measured first as total amount dispensed and then into total doses dispensed. Written/verbal instructions were documented. Results. The volume of PCN dispensed was 195 +/- 25 mL (range: 105-222 mL) for an average of 29.4 doses, where 30 doses were needed. TMP-SMX dispensed had a volume of 107 +/- 5 mL (range: 98-120 mL) resulting in an average of 16.5 doses, where 20 doses were needed. Twenty pharmacies (33%) did not dispense a measuring device. Verbal counseling by the pharmacist and written instructions were not uniformly given. Conclusions. We suggest calculating the actual volume needed plus an additional 10% to 30% of volume (depending on the viscosity). The prescription should also request a medication-measuring/administering device. Patient counseling and instruction should be expanded.
引用
收藏
页码:art. no. / e10
页数:4
相关论文
共 11 条
[1]  
*BOARD PHARM EX, 1992, 819155A BOARD PHARM
[2]  
*BOARD PHARM EX, 1992, 820155A BOARD PHARM
[3]  
*BOARD PHARM EX, 1992, 818155A BOARD PHARM
[4]  
GASTANADUY AS, 1980, LANCET, V2, P498
[5]   5 VS 10 DAYS OF PENICILLIN-V THERAPY FOR STREPTOCOCCAL PHARYNGITIS [J].
GERBER, MA ;
RANDOLPH, MF ;
CHANATRY, J ;
WRIGHT, LL ;
DEMEO, K ;
KAPLAN, EL .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1987, 141 (02) :224-227
[6]   RECURRENCE RATE OF STREPTOCOCCAL PHARYNGITIS RELATED TO ORAL PENICILLIN [J].
GREEN, JL ;
RAY, SP ;
CHARNEY, E .
JOURNAL OF PEDIATRICS, 1969, 75 (02) :292-&
[7]   PHARMACISTS DISPENSING ACCURACY IN A HIGH-VOLUME OUTPATIENT PHARMACY SERVICE - FOCUS ON RISK MANAGEMENT [J].
GUERNSEY, BG ;
INGRIM, NB ;
HOKANSON, JA ;
DOUTRE, WH ;
BRYANT, SG ;
BLAIR, CW ;
GALVAN, E .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1983, 17 (10) :742-746
[8]  
JONVILLE APE, 1991, ANN PHARMACOTHER, V25, P113
[9]   PENICILLIN-V FOR GROUP-A STREPTOCOCCAL PHARYNGOTONSILLITIS - A RANDOMIZED TRIAL OF 7 VS 10 DAYS THERAPY [J].
SCHWARTZ, RH ;
WIENTZEN, RL ;
PEDREIRA, F ;
FEROLI, EJ ;
MELLA, GW ;
GUANDOLO, VL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1981, 246 (16) :1790-1795
[10]   5 VERSUS 10 DAYS TREATMENT OF GROUP-A STREPTOCOCAL PHARYNGOTONSILLITIS - A RANDOMIZED CONTROLLED CLINICAL-TRIAL WITH PHENOXYMETHYL-PENICILLIN AND CEFADROXIL [J].
STROMBERG, A ;
SCHWAN, A ;
CARS, O .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1988, 20 (01) :37-46